Next Article in Journal
Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
Next Article in Special Issue
Aerosol Transmission of Filoviruses
Previous Article in Journal
The Effect of MicroRNA bantam on Baculovirus AcMNPV Infection in Vitro and in Vivo
Previous Article in Special Issue
Validation of the Filovirus Plaque Assay for Use in Preclinical Studies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240

by
Viruses Editorial Office
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland
Viruses 2016, 8(5), 137; https://doi.org/10.3390/v8050137
Submission received: 9 May 2016 / Accepted: 9 May 2016 / Published: 18 May 2016
(This article belongs to the Collection Advances in Ebolavirus, Marburgvirus, and Cuevavirus Research)
The Viruses Editorial Office wishes to notify its readers of corrections in [1].
The authors refer to [2], writing that the experiments were done using 126 mM/kg/day for mouse treatment without side effects. The correct dose used in [2] was 126 µmol/kg/day.
On page 6235, the last sentence of the first paragraph should read: “These data are in line with published reports on the absence of significant toxicity caused by the inhibitor at the concentration below 75–100 M in Madin-Darby canine kidney cells (MDCK), human hepato cellular carcinoma cells (HUH), HepG2 cells or ex vivo in human peripheral blood monocytes [13], as well as in a mouse model where NHC was provided up to 126 µmol per kilogram of body weight during five consecutive days without any measurable side effects [13]”.
The original Figure 3 was in French and has been replaced by the following:
Viruses 08 00137 g001
The manuscript will be updated and the original will remain available on the article webpage. The authors would like to apologize for any inconvenience caused.

References

  1. Reynard, O.; Nguyen, X.-N.; Alazard-Dany, N.; Barateau, V.; Cimarelli, A.; Volchkov, V.E. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233–6240. [Google Scholar] [CrossRef] [PubMed]
  2. Stuyver, L.J.; Whitaker, T.; McBrayer, T.R.; Hernandez-Santiago, B.I.; Lostia, S.; Tharnish, P.M.; Ramesh, M.; Chu, C.K.; Jordan, R.; Shi, J.; et al. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture. Antimicrob. Agents Chemother. 2003, 47, 244–254. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Editorial Office, V. Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240. Viruses 2016, 8, 137. https://doi.org/10.3390/v8050137

AMA Style

Editorial Office V. Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240. Viruses. 2016; 8(5):137. https://doi.org/10.3390/v8050137

Chicago/Turabian Style

Editorial Office, Viruses. 2016. "Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240" Viruses 8, no. 5: 137. https://doi.org/10.3390/v8050137

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop